# Development Plan

## 1. Introduction
This document outlines the development plan for the CompliantFlow ALM platform.

## 2. Development Phases

### Phase 1: Inception
- **Goal**: Define high-level requirements and scope.
- **Activities**:
  - Identify User Needs (USN).
  - Define primary Risks.

### Phase 2: Elaboration
- **Goal**: Establish architecture and system specifications.
- **Activities**:
  - Define System Requirements (SYS).
  - Draft Architecture Design.
  - Prototype core graph engine.

### Phase 3: Construction
- **Goal**: Implement features and verification.
- **Activities**:
  - Detailed Design (SDS).
  - Implementation of Pydantic models and NetworkX logic.
  - Creation of Verification Tests (TC-VER).
  - Execution of Unit and Integration tests.

### Phase 4: Transition
- **Goal**: Validation and Release.
- **Activities**:
  - Validation Testing (TC-VAL).
  - User Acceptance.
  - Release packaging.

## 3. Development Standards, Methods and Tools

The following standards, methods, and tools are applied throughout development:

- **Standards**: IEC 62304 (medical device software), ISO 14971 (risk management)
- **Methods**: Model-based requirements (YAML), graph-based traceability, GitOps approval workflow
- **Tools**: Python, pytest, Git, GitHub Actions CI/CD, CompliantFlow CLI

## 4. Defect Management

Categories of software defects that may be introduced and corresponding controls:

- **Logic defects**: Detected via automated test suite (pytest) run on every pull request
- **Data integrity defects**: Detected via schema validation in DHF loader
- **Traceability defects**: Detected via `compliantflow validate traceability`
- **Regression defects**: Detected via CI pipeline regression tests on every merge

Evidence that defects do not contribute to unacceptable risk is provided by:
- CI pipeline test results stored in `DHF/test-results/results.yaml`
- Risk analysis items (RISK) linked to risk control measures (RCM)
